Molecular point-of-care testing using nucleic acid amplification technology (NAAT) enables rapid, accurate, and on-site detection of infectious diseases by identifying pathogen-specific genetic material. These tests combine laboratory-grade molecular precision with near-patient convenience, making them essential in emergency departments, clinics, pharmacies, and even home-based care. https://www.databridgemarketresearch.com/reports/global-molecular-point-of-care-testing-using-naat-market